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Objective: In growth plate chondrocytes, loss of Dicer, a microRNA (miRNA)-processing enzyme, causes
defects in proliferation and differentiation, leading to a lethal skeletal dysplasia. However roles of
miRNAs in articular chondrocytes have not been deﬁned in vivo. To investigate the role of miRNAs in
articular chondrocytes and to explore the possibility of generating a novel mouse osteoarthritis (OA)
model caused by intrinsic cellular dysfunction, we ablated Drosha, another essential enzyme for miRNA
biogenesis, exclusively in articular chondrocytes of postnatal mice.
Design: First, to conﬁrm that the essential role of miRNAs in skeletal development, we ablated the
miRNA biogenesis pathway by deleting Drosha or DGCR8 in growth plate chondrocytes. Next, to inves-
tigate the role of miRNAs in articular cartilage, we deleted Drosha using Prg4-CreERT transgenic mice
expressing a tamoxifen-activated Cre recombinase (CreERT) exclusively in articular chondrocytes.
Tamoxifen was injected at postnatal days, 7, 14, 21, and 28 to ablate Drosha.
Results: Deletion of Drosha or DGCR8 in growth plate chondrocytes caused a lethal skeletal defect similar
to that of Dicer deletion, conﬁrming the essential role of miRNAs in normal skeletogenesis. Early post-
natal Drosha deletion in articular chondrocytes signiﬁcantly increased cell death and decreased Safranin-
O staining. Mild OA-like changes, including surface erosion and cleft formation, were found in male mice
at 6 months of age; however such changes in females were not observed even at 9 months of age.
Conclusions: Early postnatal Drosha deﬁciency induces articular chondrocyte death and can cause a mild
OA-like pathology.
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Osteoarthritis (OA) is the most prevalent skeletal condition in
the elderly. Traditionally OA has been considered as a “wear-and
tear” disease caused by cumulative mechanical stress during the
aging process. However, this view of OA is changing as accumu-
lating evidence demonstrates the involvement of other mecha-
nisms that promote OA initiation and progression. Articular
chondrocytes from old individuals show signs of age-related
cellular dysfunction including telomere shortening, DNA dam-
ages, and cellular senescence-associated phenotypes1e4. Therefore,td. All rights reserved.
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articular chondrocytes likely contribute to the disease3. Chon-
drocyte dysfunction during developmental and mature stages
likely impairs cartilage structure and function, whereas during
degeneration stages, chondrocytes produce catabolic enzymes such
as metalloproteases (MMP's) and facilitate cartilage matrix degra-
dation. Thus, articular chondrocytes presumably play different
roles depending on stages of life; however, stage-speciﬁc articular
chondrocyte function has not been precisely deﬁned.
microRNAs (miRNAs) regulate gene expression mainly at the
post-transcriptional level. miRNAs are generated from long primary
transcripts (pri-miRNAs) after multi-step processing; ﬁrst pri-
mRNAs are processed into small hairpin RNA (pre-miRNAs) by the
microprocessor complex comprised of Drosha and DGCR8, and then
further processed by the RNase III, Dicer.We have shown that global
reduction inmiRNAs by deletingDicer in growth plate chondrocytes
reduces cellular proliferation and accelerate chondrocyte differen-
tiation, causing a severe skeletal growth defect and early postnatal
lethality5.Wehavealso shown that suppression of let-7miRNAs, the
most abundant miRNAs in chondrocytes, reduces chondrocyte
proliferation in the growth plate cartilage6. However, in articular
cartilage, despite many studies have suggested possible involve-
ment of miRNAs in physiological and pathological processes of
articular chondrocytes7, except the report that miR-140 deﬁciency
causes OA inmice8, the role of miRNAs in vivo is still largely unclear.
This is primarily due to the lack of adequate mouse tools that allow
genetic manipulation in an articular chondrocyte-speciﬁc manner.
In this study, we conditionally deleted Drosha using Cre trans-
genic mice (Prg4-CreERT) in which a tamoxifen-inducible Cre
recombinase (CreERT) was expressed under the endogenous pro-
moter of the Prg4 (lubricin) gene. We show that early postnatal
deletion of Drosha in articular chondrocytes increases cell death,
decreases matrix proteoglycan content, and can cause mild OA-like
structural changes. These ﬁndings suggest that miRNAs are essen-
tial for articular chondrocyte survival and structural soundness of
the articular cartilage.
Methods
Mice
Floxed Drosha9, ﬂoxed DGCR810, Col2-Cre transgenic11 and Prg4-
CreERT knock-in mice were described12,13. Genotyping of Prg4-
CreERT mice was performed by PCR using the primers, Pr224
(common) 50-TCAGGAATTCAAGCTGATTGC-30 and Pr226 (CreERT
allele speciﬁc) 50-AACTTGTGGCCGTTTACGTC-30 and Pr227 (wild-
type allele speciﬁc) 50-CCTTGAGATGAAACCTGTTGAATC-3’. The
Prg4-CreERT allele and wildtype Prg4 allele produce 420 bp- and
235 bp-long PCR amplicons, respectively. Mice used in this study
were in a C57/BL6-dominant mixed background.
Tamoxifen was dissolved in sunﬂower oil at the concentration of
10 mg/mL. Mice were injected 0.1 mg/g BW intraperitoneally at
postnatal day (P) 7, 14, 21, and 28. Mice were sacriﬁced at indicated
ages. Tissues were ﬁxed in 10% neutralized formalin for 2 days and
decalciﬁed in 15% Ethylenediaminetetraacetic acid (EDTA) for up to 3
weeks. Although Prg4-CreERT allele is a functionally null allele,
because heterozygous Prg4-null mice show normal articular carti-
lage14,Cre-negative littermateswereusedascontrol in this study. This
study was approved by the Institutional Animal Care and Use Com-
mittee of Massachusetts General Hospital.
Whole-mount X-gal staining
Whole-mount X-gal staining was performed as described15.
Brieﬂy, after sacriﬁcing mice, limbs were dissected, and ﬁxed in 10%formalin on ice for an hour. Specimens were washed with phos-
phate buffered saline (PBS) at room temperature for 30 min twice,
and transferred into a staining solution containing PBS, 2 mM
MgCl2, 5 mM potassium-ferricyanide, 5 mM potassium-
ferrocyanide, 0.02% IGEPAL, 0.01% sodium deoxycholate, and
1 mg/mL X-gal. Specimens were incubated at room temperature
rocking for 4 h to facilitate substrate penetration, then incubated at
37C for 24 h. Specimens were rinsed with PBS, and post ﬁxed with
10% formalin for a day, decalciﬁed, and processed for sectioning.
qRT-PCR
Quantitative reverse transcription polymerase chain reaction
(qRT-PCR) was performed using the EvaGreen master mix reagent
(Solis Biodyne) and ABI StepOne realtime PCR (Applied Biosystems)
with following primers: Drosha-L, 50-GGACCATCACGAAGGACACT-
30 and Drosha-R, 50-CACGGGTCTCTTGGTTTTGT-30; DGCR8-L,50-
GAAACCATGGAATGGGTGACA-30 DGCR8-R, 50-TGTGGGTGCAGTAG-
CTGAAG-30; Actb-L, 50-GCACTGTGTTGGCATAGAGG-30 and Actb-R,
50-GTTCCGATGCCCTGAGGCTCTT-30. miRNA quantiﬁcation was
performed using the MirVana mirVana qRT-PCR miRNA Detection
Kit (Life Technologies). mRNA expression levels were normalized
by beta actin (Actb) and miRNA levels were normalized by U6.
Histological analyses
Formalin-ﬁxed mouse tissues were parafﬁn-processed, cut, de-
waxed, and rehydrated for hematoxylineeosin and Safranin-O
staining, and other histological analyses.
TUNEL assay
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay was performed using the Cell death detection kit
(Roche) according to the manufacturer's instruction.
BrdU labeling and staining
For BrdU labeling and detection, 0.1 mg/g BW BrdUwas injected
into pregnant mothers 2 h before sacriﬁce. Bones of embryos were
dissected, ﬁxed, processed, sectioned, and subjected to BrdU
staining using the BrdU staining kit (Life technologies).
In situ hybridization
In situ hybridizationwas carried out as described16 using probes
previously described17.
Statistical analysis
Data are expressed as mean þ 95% conﬁdence interval. Differ-
ences of two groups were tested using Student's t test. Statistical
analysis was performed using the Prism 6 software (Graphpad).
Results
Deletion of DGCR8 or Drosha in growth plate chondrocytes causes a
skeletal developmental defect
We have previously shown that deletion of Dicer in growth plate
chondrocytes decreases cellular proliferation5. Since Dicer is
involved in other biological functions in addition to miRNA
biogenesis18, in order to conﬁrm that the miRNA deﬁciency was
responsible for the skeletal defect caused by chondrocyte-speciﬁc
Dicer deletion, we generated mice missing function of the
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growth plate chondrocytes. Floxed Drosha or ﬂoxed DGCR8 mice
were crossed with Cre transgenic mice expressing Cre under the
control of a mouse type II collagen promoter (Col2-Cre) to generate
homozygous conditional knockout mice (cKO) for Drosha or DGCR8.
Both Drosha and DGCR8 cKOmice showed perinatal lethality unlike
Dicer cKO mice that survive a few weeks postnatally. However, like
in Dicer cKO mice5, the skull shape of Drosha and DGCR8 cKO mice
was deformed due to the reduced longitudinal growth [Fig. 1(A),
(B)]. Development and mineralization of skeletal elements of these
mice, including vertebrae, were poor [Fig. 1(C), (D)]. We conﬁrmed
that expression levels of several miRNAs, and Drosha or DGCR8
were reduced in primary chondrocytes of Drosha or DGCR8 cKO
embryos [Fig. 1(E), (F)]. We also found proliferation defects in
Drosha and DGCR8 cKO growth plates, which was a major cellular
change in Dicer cKO mice5 (Fig. 2). This reduced the size of the
proliferating chondrocyte domain. The reductions in size of the
proliferating chondrocyte domain were best appreciated in the
bidirectional growth plates in the basal skull (Fig. 3). The prolifer-
ating domain, positive for Col2a1 and ﬂanked by Col10a1-express-
ing hypertrophic chondrocytes, was reduced in DGCR8 and Drosha
cKO mice (Fig. 3), which was also observed in Dicer cKO mice5. This
ﬁnding that deletion of a component of the microprocessor com-
plex, Drosha or DGCR8, resulted in defects similar to that Dicer cKO
mice strongly suggests that miRNA deﬁciency is responsible for the
skeletal phenotypes of these mice.Efﬁcient tamoxifen-induced recombination by Prg4-CreERT
transgenic mice
Unlike growth plate chondrocytes that vigorously proliferate,
differentiate, and die, articular chondrocytes proliferate slowly and
persist throughout life. In order to investigate the role of miRNAs in
articular chondrocytes, we deleted Drosha in postnatal articular
chondrocytes. To target articular chondrocytes, we used Prg4-
CreERT transgenic mice in which tamoxifen-inducible CreERT was
expressed under the control of the endogenous promoter of the
Prg4 gene that encodes proteoglycan 4 (lubricin). Lubricin, also
called superﬁcial zone protein (SZP), is expressed in superﬁcial
zone chondrocytes of the articular cartilage but not in growth plate
chondrocytes14.
First, we tested the Cre dependent recombination efﬁciency
after four doses of tamoxifen injection. Prg4-CreERT mice were
crossed with R26R Cre reporter mice19 that express LacZ upon Cre-Fig. 1. Chondrocyte-speciﬁc deletion of a microprocessor component, Drosha or DGCR8, caus
using Col2-Cre transgenic mice. Skeletal preparations of cKO mice cKO of DGCR8 (A, C), and D
skeletal growth compared with Cre-negative control littermates (Ctrl). Reductions in expr
Drosha (F) cKO mice. Scale bars, 0.5 mm (A, B) and 0.25 mm (C, D). All miRNAs and genesdependent recombination. We injected 0.1 mg/g BW tamoxifen to
mice at postnatal day (P) 7, P14, P21, and P28. At P30, Cre-
dependent recombination was found in approximately 50% of su-
perﬁcial, middle and deep zone chondrocytes in the area above the
tidemark [Fig. 4(A) and (A0)]. At P60, the number of LacZ-positive
cells somewhat increased compared with that at P30, suggesting
that Prg4-positive cells and their descendants still slowly prolifer-
ate during this period [Fig. 4(B)].
Postnatal articular chondrocyte-speciﬁc Drosha deletion can cause
mild OA-like changes
With this injection regimen, we administered tamoxifen to
Prg4-CreERT:Droshaﬂ/ﬂ (cKO) mice and sex-matched control litter-
mates. Mice were sacriﬁced at 2, 4, 6, and 9 months of age. At 2
month of age, we found a patchy reduction in Safranin O staining in
the tibial articular cartilage of cKO mice, which was exacerbated at
4 month of age [Fig. 5(A)]. The structural integrity of the articular
cartilage was relatively well preserved at 4 months of age. At 6
months of age, damages of the articular surface and cartilage ma-
trix, including surface erosion and clefts, started appearing in male
cKO mice [Fig. 5(A), (B)]. We did not observe overt morphological
changes in synovial tissues (Supplementary Fig. 1). In female mice,
these changes except the reduced Safranin O staining were not
observed at 6 and 9 months of age (Supplementary Fig. 2). In order
to investigate the mechanism for the reduced proteoglycan content
in cKO cartilage, we evaluated expression of ADAMTS5, a major
aggrecanase encoded by Adamts5. We did not ﬁnd overt upregu-
lation in ADAMTS5 in 2 month-old cKO cartilage (Supplementary
Fig. 3(B)). In addition, we quantiﬁed gene expression of aggrecan
(Acan), decorine (Dcn), Sox9, and Adamts5 in primary rib chon-
drocytes isolated from Col2-Cre:Droshaﬂ/ﬂ cKO embryos. We found
signiﬁcant reductions in Acan and Sox9, whereas Adamts5 expres-
sionwas unaffected in cKO chondrocytes (Supplementary Fig. 3(B)).
These results suggest that the reduced proteoglycan content in cKO
mice is caused by the reduction in proteoglycan production due to
chondrocyte dysfunction rather than increased catabolism.
Drosha deletion induces cell death of articular chondrocytes
To investigate themechanisms,weperformed theTUNELassay to
assess cell death. In control articular cartilage, cell death were
detected only in calciﬁed zone chondrocytes below the tidemark,
whereasDrosha cKO showed signiﬁcant numbers of TUNEL-positivees lethal skeletal dysplasia. Drosha or DGCR8 was deleted in growth plate chondrocytes
rosha (B, D) mice at E18.5. DGCR8 and Drosha cKO mice show deformed skulls and poor
ession of indicated miRNAs and genes in primary rib chondrocytes in DGCR8 (E) and
showed signiﬁcant reductions in cKO mice. (n ¼ 4, P < 0.001).
Fig. 2. Reduced chondrocyte proliferation of DGCR8 and Drosha cKO growth plates. BrdU positive cells and total nuclei of periarticular chondrocytes (PA; indicated by red dotted
lines) and columnar proliferating chondrocytes (C; indicated by black dotted lines) were counted on the proximal tibial growth plate of E17.5 embryos of control (Ctrl) and cKO mice.
The BrdU labeling index was calculated by dividing the number of BrdU-positive nuclei by the total number of nuclei. Three mice each genotype were analyzed (n ¼ 3).
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4 months of age [Fig. 6(A), (B)]. We did not ﬁnd BrdU positive
articular chondrocytes either in 4 month-old control or cKO mice
after 3 weeks of daily BrdU injection, conﬁrming the very low pro-
liferation rate of articular chondrocytes (data not shown). Therefore,
the major consequence of postnatal Drosha deletion in articular
chondrocytes appears to be cell death unlike in developing growth
plates in which Drosha deﬁciency causes a proliferation defect. We
didnotobserveupregulationofmatrixmetalloproteinase-13 (MMP-
13) or discoidin domain-containing receptor 2 (DDR-2), ones of
markers often upregulated in OA20 (Supplementary Fig. 4).
Discussion
In this study, we demonstrate that ablation of microprocessor
function via genetic deletion of Drosha or DGCR8 in growth plateFig. 3. Reduced proliferating chondrocytes of the basiosphenoidal/basioccipital growth plat
E18.5 embryos were subjected to H/E staining and in situ hybridization for Col10a1 and Cochondrocytes causes a skeletal defect similar to that of Dicer-deﬁ-
ciency. This suggests that miRNA deﬁciency is responsible for the
reduction in growth plate chondrocyte proliferation and skeletal
defects in these mutant mice.
Although qualitatively similar, Dicer deletion shows some-
what milder abnormalities compared with deletion of Drosha or
DGCR8. The precise reason for the differences in phenotypical
severity among these models is unknown. Other than the trivial
possibilities, such as different efﬁciencies in gene deletion or
miRNA elimination, since both Dicer and Drosha are known
to acts on non-miRNA substrates21,22, it is also formally possible
that loss of additional functions other than miRNA biogenesis
that these miRNA processing enzymes possess might contribute
to the difference in the skeletal defect severity of these mice.
Nevertheless, the ﬁnding that these mice show qualitatively
similar abnormalities strongly suggests that miRNA deﬁciencye in the basal skull in DGCR8 and Drosha cKO mice. Sagital sections of the basal skull of
l2a1. P, pituitary gland. Scale bar, 100 mm.
Fig. 4. Efﬁcient postnatal tamoxifen-induced, Prg4CreERT-dependent DNA recombi-
nation in articular chondrocytes. Transgene mice doubly positive for the Prg4-CreERT
and R26R Cre reporter alleles were injected with tamoxifen at P7, 14, 21, and 28. Whole
mount X-gal staining shows X-gal-positive cells in superﬁcial and middle zone chon-
drocytes at P30 (A and A0) and P60 (B).
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mice.
Tissue-speciﬁc genetic manipulation in postnatal articular
chondrocytes has been difﬁcult due to the lack of adequate genetic
tools. While Gdf5-Cre transgenic mice has been used to delete genesFig. 5. Histological changes caused by postnatal deletion of Drosha in articular chondrocyte
and Drosha cKO male mice. Sagital sections of the medial tibial plateau at indicated ages are
of the cartilage tissue is relatively well preserved until 4 months. (B) H/E stained section o
(black arrows), vertical (single yellow arrows) and horizontal clefts (double yellow arrow) a
Fig. 1). More than two cKO mice with each sex were analyzed at each time point. (C) Reduc
above the tidemark of the tibial plateau were counted in mice at indicated ages. (n ¼ 3).exclusively in articular chondrocytes and synovial tissues23, its
expression is limited to embryonic stages. Therefore, it was not
possible tomanipulategenespostnatally inanarticularchondrocyte-
speciﬁc manner using this Cre line. Unlike Gdf5, Prg4 expression in-
creases in postnatal stages probably because Prg4 is induced by
variousphysiological stimuli13. Thus far, thePrg4-CreERTmouse is the
only Cre line that allows gene deletion in postnatal articular chon-
drocytes but not in growth plate chondrocytes. With the tamoxifen
injection regimen used in this study, we demonstrate that the Prg4-
CreERT transgenic line is a useful tool to manipulate genes in post-
natal articular chondrocytes with a reasonable efﬁciency.
We have demonstrated that early postnatal deletion of Drosha in
Prg4-expressing cells and their descendants causes cell death, re-
duces the proteoglycan content in articular cartilage, and can
induce OA-like changes. While Drosha deletion in growth plate
chondrocytes primarily caused a proliferation defect, it resulted in
cell death in articular chondrocytes. This disparity in consequences
of Drosha deletion is likely reﬂecting the difference in the speed of
cellular turnover between these two cartilage tissues. Growth plate
chondrocytes proliferate vigorously, differentiate, die, and are
constantly replaced, whereas articular chondrocytes proliferate
slowly and stay in the tissue permanently. Since cell death appears
to be a relatively late consequence of Drosha deletion, cell death
may be difﬁcult to observe in the growth plate whose turnover is
rapid whereas proliferation defects may not be easy to detect in
slowly proliferating articular chondrocytes.
The reduction in proteoglycan content was the most noticeable
change whereas structural changes such as cleft formation were
relatively mild and only observed at later stages in male mice. This
is in line with the previous ﬁndings that male mice tend to develop
OA with greater severities and frequency than females in various
OA models24e28. Although precise mechanisms are unknown,s. (A) Safranin O staining of the articular cartilage of the proximal tibia of control (Ctrl)
shown. Reduced Safranin O staining is noted at 2 months, while the structural integrity
f 6-month old male cKO articular cartilage. Mildly reduced cellularity, surface erosion
re present. These structural changes are minimal in female cKO mice (Supplementary
ed cellularity in Drosha-deﬁcient cartilage. Cell numbers per an arbitrarily deﬁned area
Fig. 6. Increased cell death in the superﬁcial and mid zones in Drosha cKO cartilage at 4 months old. Both control (Ctrl) and cKO mice show TUNEL-positive cells in the calciﬁed zone
below the tidemark (dotted lines), whereas cKO mice show a signiﬁcant increase in number of TUNEL-positive cells in the superﬁcial, middle, and deep zones above the tidemark at
4 and 6 months. TUNEL-positive cells above the tidemark were counted, normalized by the total number of cells, and compared. Double arrows indicate the articular cartilage. Scale
bar, 50 mm. (n ¼ 3).
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been proposed to play roles in the sex-dependent difference in OA.
Even with the substantial cell death and the markedly reduced
proteoglycan content, the cartilage structure was relatively well
preserved in our model. The degrees of OA-like changes assessed by
the semi-quantitative Ostaoarthritis Research Society International
(OARSI) mouse OA scoring system29 were grade 1e2 (average 1.67)
in the 6 month-old male cKO mice that showed most severe
changes in this study, whereas other mice showed only a reduction
in Safranin O staining (grade 0.5). A previous study demonstrated
that postnatal deletion of Sox9 in cartilage caused a dramatic
reduction in proteoglycan content in the articular cartilage without
overt osteoarthritic changes30. This suggests that articular chon-
drocyte dysfunction does not signiﬁcantly affect the maintenance
of the articular cartilage structure once the tissue is established,
which may explain why we observed relatively mild changes in the
articular cartilage structure despite the substantial cell death
caused by Drosha deﬁciency. In our study, Drosha was disrupted in
early postnatal stages when mouse skeleton were still rapidly
growing. Although we did not ﬁnd overt morphological abnor-
malities in articular cartilage development, it is possible that
chondrocyte dysfunction caused by Drosha-deﬁciency during
developmental stages compromises the quality and/or quantity of
matrix proteins, and might cause cartilage matrix fragility, leading
to mild OA-like changes at later stages in some mice. Applying
greater mechanical stresses, such as surgical OA induction and
aging, may reveal the possible matrix fragility of Drosha-deﬁcient
cartilage.
In summary, this study demonstrates that Drosha is necessary
for postnatal articular chondrocyte survival and maintenance of
normal proteoglycan content in the cartilage. Because Drosha is
necessary for biogenesis of most miRNAs, this effect is likely
mediated by global deﬁciency of miRNAs; understanding speciﬁc
roles of individual miRNAs in articular chondrocytes in vivo is an
important future research agenda. Although the cartilage structure
was relatively well preserved, mild OA-like changes can develop in
some Drosha cKO mice in 6 months of age. Thus, inducing articular
chondrocyte dysfunction at early postnatal stages via Drosha
deletion may provide a novel mouse OA model.
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